Fitlife Brands, Inc. (FTLF): Revenue

Annual figures by period end, from SEC filings.

$81.46M
Year ended 2025-12-31
$101.27M
Trailing 12 months to 2026-06-30
+41.4%
3-year compound annual growth
+29.8%
5-year compound annual growth
2019-12-31: $19.14M2020-12-31: $22.11M2021-12-31: $27.91M2022-12-31: $28.80M2023-12-31: $52.70M2024-12-31: $64.47M2025-12-31: $81.46M$81.46M
2019-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$81.46M+26.4%2026-03-31, From 2025-01-01
2024-12-31$64.47M+22.3%2026-03-31, From 2024-01-01
2023-12-31$52.70M+83.0%2025-03-27, From 2023-01-01
2022-12-31$28.80M+3.2%2024-03-29, From 2022-01-01
2021-12-31$27.91M+26.2%2023-03-24, From 2021-01-01
2020-12-31$22.11M+15.5%2022-10-13, From 2020-01-01
2019-12-31$19.14Mn/a2022-10-13, From 2019-01-01

Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Fitlife Brands, Inc. (FTLF)2025-12-31$81.46M+26.4%
Mannatech Inc (MTEX)2025-12-31$108.04M-8.3%
Niagen Bioscience, Inc. (NAGE)2025-12-31$129.42M+29.9%
Natural Alternatives International Inc (NAII)2026-06-30$142.51M+9.7%
Cronos Group Inc. (CRON)2025-12-31$146.59M+24.6%
Marimed Inc. (MRMD)2025-12-31$159.83M+1.3%
Glass House Brands Inc. (GLAS)2025-12-31$181.98M-9.4%
Leef Brands Inc. (LEEEF)2025-12-31$34.79M+22.1%
biote Corp. (BTMD)2025-12-31$192.22M-2.5%

Compare FTLF, MTEX, NAGE, NAII side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗